Dana-Farber Cancer Institute investigators have developed an online, easy-to-use tool that more accurately predicts when a precursor blood condition called smoldering multiple myeloma is likely to turn into active cancer than existing predictive models. It identifies patients who are at a high risk of developing multiple myeloma and would benefit from treatment and enables doctors to spare those at low risk of progression from unnecessary treatment.
This article was originally published on MedicalXpress.com
